hercules technology sbic management, LLC

400 hamilton avenue
suite 310
palo alto, california 94301

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 26, 2013

NYS DOS ID#
4436723

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - HERCULES TECHNOLOGY SBIC MANAGEMENT, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Tuesday Jun 20, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy New York
  • Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal
    By David Holley - Monday Jun 19, 2017

    Dallas—In Teladoc’s acquisition of Boston-based Best Doctors—a $440 million cash-and-stock deal that the companies announced Monday—Teladoc (NYSE: TDOC) is gaining a business that lets it offer more specialization in its telemedicine services. Best Doctors connects individuals who have tough decisions to make about treatments—or who want a second opinion about a diagnosis—with top-rated doctors worldwide. […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Element Raises $102 Million | Crunch Report
    By Khaled "Tito" Hamze - Wednesday Jun 14, 2017

    Element AI raises $102 Millon, Another board member resigns from Uber and Chan Zukerberg Initiative invests $5 million into Landed to help teachers afford housing in Palo Alto. All this on Crunch Report. Read More

    Source: TechCrunch
  • Flipboard Hits Two Years, 20 Million Users
    Thursday Aug 30, 2012

    Popular newsreader app Flipboard today announced hitting 20 million users two years after launching as a way for people to aggregate content in a magazine-style format. In the last year, the PaloAlto-based app was extended from its original home on the iPad to the iPhone and Android and BlackBerry devices.

    Source: Media Post: MAD SF
  • Charles Thacker, key designer of the Xerox Alto, dies at 74
    By Cyrus Farivar - Tuesday Jun 13, 2017

    Every computer we use today owes a debt to the legendary and influential machine.

    Source: Ars Technica
  • Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
    Tuesday Jun 13, 2017

    Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.

    Source: The Wall Street Journal: U.S. Business
  • Girl Scouts will become white hat hackers with new cybersecurity badges
    By Brett Williams - Saturday Jun 17, 2017

    Girl Scouts will soon be ready to take over your IT department. 

    The organization is teaming up with Palo Alto Networks, an internet security company, to introduce a set of new badges to promote computer and internet literacy and cybersecurity. The initiative aims to foster educational programs across all ages of the Girl Scouts, with a major emphasis on providing access to girls who might otherwise never be exposed to the field.

    The 18 new badges will be available to Girl Scouts across the US starting in September 2018. 

    More about Girl Scouts, Women In Tech, Stem Gender Gap, Coding Education, and White Hat Hacker

    Source: Mashable!
  • In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions
    By Alex Lash - Wednesday May 31, 2017

    Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck’s drug pembrolizumab (Keytruda), already one of the world’s most successful cancer immunotherapies, could now treat any tumor with a particular genetic fingerprint. It was the first time a drug has been […]

    Source: Xconomy New York